Dogwood Therapeutics Files Definitive Proxy Statement
Ticker: DWTX · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1818844
| Field | Detail |
|---|---|
| Company | Dogwood Therapeutics, INC. (DWTX) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: DWTX
TL;DR
Dogwood Therapeutics (DWTX) filed its proxy statement for the June 18th meeting. Shareholders vote on company matters.
AI Summary
Dogwood Therapeutics, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 18, 2025. The company, formerly known as Virios Therapeutics, Inc., is in the pharmaceutical preparations industry. The filing details information related to the solicitation of proxies for the meeting.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, influencing corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine filing of a proxy statement, which is standard for publicly traded companies.
Key Numbers
- 20250618 — Annual Meeting Date (Date for which proxies are being solicited.)
- 20250430 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Dogwood Therapeutics, Inc. (company) — Registrant
- Virios Therapeutics, Inc. (company) — Former company name
- Virios Therapeutics, LLC (company) — Former company name
- Securities Exchange Act of 1934 (legal_document) — Governing regulation
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to solicit proxies from shareholders for the annual meeting of Dogwood Therapeutics, Inc. scheduled for June 18, 2025.
When was Dogwood Therapeutics, Inc. formerly known as?
Dogwood Therapeutics, Inc. was formerly known as Virios Therapeutics, Inc. and Virios Therapeutics, LLC.
What is the SIC code for Dogwood Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Dogwood Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Dogwood Therapeutics, Inc.?
The business address of Dogwood Therapeutics, Inc. is 44 Milton Avenue, Alpharetta, GA 30009.
What type of filing is this document?
This document is a Definitive Proxy Statement (DEF 14A) filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Dogwood Therapeutics, Inc. (DWTX).